Pancreatic cancer is notoriously hard to treat and often resists the most advanced immunotherapies. Northwestern Medicine scientists have uncovered a novel explanation for that resistance: Pancreatic ...

BMY's growth-driving portfolio increased 17% year-over-year, prompting an upward revision in 2025 revenue guidance and ...

The start of the trial marks an expansion of the firm's oncology pipeline, and the firm hopes mRNA-2808 will be the first of many T-cell engagers in its portfolio.

For 75 years, the standard tools for autoimmune disease have consisted of steroids, cytotoxics and broad biologics that tamp down the entire immune system. They can help, but they are rarely curative.

There are a number of considerations that can help streamline the pathway to the clinic. One of the first is which vector system will be used, with AAV and lentivirus being two of the most commonly ...

Clonal hematopoiesis of indeterminate potential (CHIP) is a known risk factor for coronary artery disease, though its precise role in disease progression continues to emerge. This study leverages ...

Aurora has again pushed back the proposed purchase of equipment that would let the Aurora Police Department test the range of local cell phone towers, which would help provide additional evidence ...

A promising breakthrough in autoimmune disease research may open the door to safer and more effective treatments. Scientists ...

After surviving three types of cancer and having to face the harsh realities of colorectal and endometrial cancer and basal cell carcinoma, I know just how crucial early detection can be in saving ...

There's nothing more that Nick Mondek loves more than being a dad. But in 2022, an aggressive form of acute myeloid leukemia ...

A study from the University of Michigan Health Rogel Cancer Center and Department of Pathology shows that further testing in ...

A novel tool could reduce the time it takes to diagnose and classify acute leukemias from days to hours through DNA ...